[1] 中华医学会肝病学分会药物性肝病学组.药物性肝损伤诊治指南.肝脏,2015,20:751-758.
[2] Chalasani NP,Hayashiph,Bonkovsky HL,et al.ACG Clinical Guideline:the diagnosis and management of idiosyncratic drug-induced liver injury.Am J Gastroenterol,2014,109:950-966.
[3] 朱春雾,王海南,袁继丽,等. 445例药物性肝损伤的临床分析.临床肝胆病杂志,2018,34:354-358.
[4] Frenzel C,Teschke R.Herbal hepatotoxicity: Clinical characteristics and listing compilation.Int J Mol Sci,2016,17:E588.
[5] 张长平,崔向丽,王咏梅.药物性肝损伤200例临床分析.肝脏,2014,19:483-486.
[6] 陈永虎,杨琴琴,陈俏春.中药导致肝损害52例临床特征分析.中华危重症医学杂志(电子版),2017,10:341-342.
[7] 张艳梅,孙文静,文良志,等.近5年我国药物性肝损伤患者临床特征分析.临床肝胆病杂志,2018,34:562-566.
[8] Zhou Y,Yang L,Liao Z,et al.Epidemiology of drug-induced liver injury in china:a systematic analysis of the Chinese literature licluding 21,789 patients.Eur J Gastroenterol Hepatol,2013,25:825-829.
[9] 朱飞燕,黄德东,孔祥超,等.151例药物性肝损伤患者临床特征分析.肝脏,2017,22:705-708. |
